These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Binding of [125I]-labelled iodomelatonin in the duck thymus.
    Author: Liu ZM, Pang SF.
    Journal: Biol Signals; 1992; 1(5):250-6. PubMed ID: 1307926.
    Abstract:
    [125I]-labelled iodomelatonin binding sites in membrane preparations of duck thymus were studied. The specific binding of [125I]-labelled iodomelatonin in the duck thymus was stable, saturable, reversible and of high affinity. Scatchard analysis of the binding of [125I]-labelled iodomelatonin in the duck thymus collected at midlight had an equilibrium dissociation constant (Kd) of 34.8 +/- 9.4 pmol/l and a maximum number of binding sites (Bmax) of 0.98 +/- 0.07 fmol/mg protein. Two-point diurnal study demonstrated that the Bmax in samples collected at midlight was 42.0% higher (p < 0.05) than that at middark, but there was no significant difference (p > 0.05) between the midlight and middark Kd values. Competition inhibition studies showed that only melatonin, 2-iodomelatonin, 6-chloromelatonin, 6-hydroxymelatonin, N-acetylserotonin, 5-methoxytryptophol, and 5-hydroxytryptamine showed significant inhibition of the [125I]iodomelatonin binding in duck thymus membrane preparations, while the other compounds had no significant inhibition. Our results suggested a direct action of melatonin on the thymus and, thus, the cellular immune system.
    [Abstract] [Full Text] [Related] [New Search]